William G. Harris - 31 Jan 2022 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Director
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Issuer symbol
SLNO
Transactions as of
31 Jan 2022
Net transactions value
-$4,740
Form type
4
Filing time
02 Feb 2022, 19:31:20 UTC
Previous filing
02 Nov 2021
Next filing
14 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Award $0 +42,254 +40% $0.000000 146,870 31 Jan 2022 Direct F1
transaction SLNO Common Stock Tax liability $4,740 -13,352 -9.1% $0.3550 133,518 31 Jan 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of SLNO common stock. The RSUs are fully vested on January 31, 2022.
F2 Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the Reporting Person.